Hemoglobin catabolism and iron utilization by malaria parasites.

[1]  J T Palmer,et al.  Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors , 1996, Antimicrobial agents and chemotherapy.

[2]  S. Meshnick,et al.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. , 1996, Microbiological reviews.

[3]  P. Rosenthal,et al.  Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. , 1996, Blood.

[4]  S. Meshnick,et al.  Patterns of haemozoin accumulation in tissue , 1996, Parasitology.

[5]  D. Dive,et al.  Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum. , 1996, Molecular and biochemical parasitology.

[6]  D. Sullivan,et al.  Plasmodium Hemozoin Formation Mediated by Histidine-Rich Proteins , 1996, Science.

[7]  Fred E. Cohen,et al.  In vitro antimalarial activity of chalcones and their derivatives. , 1995, Journal of medicinal chemistry.

[8]  B. Berger,et al.  Haem polymerization in malaria , 1995, Nature.

[9]  D. Goldberg,et al.  The plasmodium digestive vacuole: metabolic headquarters and choice drug target. , 1995, Parasitology today.

[10]  D. Warhurst.  Haemozoin and the mode of action of blood schizontocides: more controversy. , 1995, Parasitology today.

[11]  P. Rosenthal,et al.  Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase , 1995, Infection and immunity.

[12]  H. Matile,et al.  Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein , 1995, Nature.

[13]  P. Rosenthal,et al.  Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. , 1995, Experimental parasitology.

[14]  Z. Cabantchik.  Iron Chelators as antimalarials: the biochemical basis of selective cytotoxicity , 1995 .

[15]  Elizabeth C. Theil.  Iron regulatory elements (IREs): a family of mRNA non-coding sequences. , 1994, The Biochemical journal.

[16]  S. Meshnick,et al.  Effects of antimalarials and protease inhibitors on plasmodial hemozoin production. , 1994, Molecular and biochemical parasitology.

[17]  B. Dunn,et al.  High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum , 1994, FEBS letters.

[18]  T. Egan,et al.  Quinoline anti‐malarial drugs inhibit spontaneous formation of β‐haematin (malaria pigment) , 1994 .

[19]  S. Meshnick,et al.  Reaction of antimalarial endoperoxides with specific parasite proteins , 1994, Antimicrobial Agents and Chemotherapy.

[20]  H. Ginsburg,et al.  Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates – a possible mechanism of their anti-malarial effect? , 1994, Parasitology.

[21]  G. Reddy,et al.  Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. , 1994, Molecular and biochemical parasitology.

[22]  I. Gluzman,et al.  Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. , 1994, The Journal of clinical investigation.

[23]  I. Gluzman,et al.  Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. , 1994, The EMBO journal.

[24]  H. Ginsburg,et al.  Hemoglobin denaturation and iron release in acidified red blood cell lysate--a possible source of iron for intraerythrocytic malaria parasites. , 1993, Experimental parasitology.

[25]  B. Cooperman,et al.  Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C D Fitch,et al.  Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine. , 1993, Biochimica et biophysica acta.

[27]  S. Meshnick,et al.  Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu) , 1993, Antimicrobial Agents and Chemotherapy.

[28]  F E Cohen,et al.  Structure-based inhibitor design by using protein models for the development of antiparasitic agents. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J W Eaton,et al.  Hemoglobin catabolism and host-parasite heme balance in chloroquine-sensitive and chloroquine-resistant Plasmodium berghei infections. , 1993, The American journal of tropical medicine and hygiene.

[30]  P. Rosenthal,et al.  Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. , 1993, The Journal of clinical investigation.

[31]  D. Parry,et al.  Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. , 1992, The New England journal of medicine.

[32]  K. Haldar,et al.  A transferrin-independent iron uptake activity in Plasmodium falciparum-infected and uninfected erythrocytes. , 1992, Molecular and biochemical parasitology.

[33]  G. Padmanaban,et al.  de novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite. , 1992, Biochemical and biophysical research communications.

[34]  E. Bailly,et al.  Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor). , 1992, The Journal of protozoology.

[35]  D. V. Vander Jagt,et al.  Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum. , 1992, Biochimica et biophysica acta.

[36]  P. Rosenthal,et al.  Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum. , 1992, Molecular and biochemical parasitology.

[37]  A. Cerami,et al.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites , 1992, Nature.

[38]  J T Palmer,et al.  Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. , 1991, The Journal of clinical investigation.

[39]  S. Lytton,et al.  Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal. , 1991, Molecular pharmacology.

[40]  G. Padmanaban,et al.  Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Chait,et al.  Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease , 1991, The Journal of experimental medicine.

[42]  J. Beesley,et al.  Mitochondria of mammalian Plasmodium spp. , 1991, Parasitology.

[43]  D. Goldberg,et al.  An iron-carboxylate bond links the heme units of malaria pigment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Oppenheim,et al.  Biochemical characterization of Plasmodium falciparum hemozoin. , 1990, The American journal of tropical medicine and hygiene.

[45]  S. Meshnick,et al.  Parasite uptake of desferroxamine: a prerequisite for antimalarial activity , 1990, British journal of haematology.

[46]  D. Goldberg,et al.  Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[47]  W. Wernsdorfer,et al.  Malaria: Principles and Practice of Malariology , 1989 .

[48]  D. Warhurst,et al.  The composition of haemozoin from Plasmodium falciparum. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[49]  P. Rosenthal,et al.  A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. , 1988, The Journal of clinical investigation.

[50]  J. L. Mego,et al.  Purification of Plasmodium falciparum digestive vacuoles and partial characterization of the vacuolar membrane ATPase. , 1988, Molecular and biochemical parasitology.

[51]  T. Peto,et al.  Deferoxamine inhibition of malaria is independent of host iron status , 1988, The Journal of experimental medicine.

[52]  J. Flippen-Anderson,et al.  Arteether, a new antimalarial drug: synthesis and antimalarial properties. , 1988, Journal of medicinal chemistry.

[53]  S. Pollack,et al.  Inability to detect transferrin receptors on P. falciparum parasitized red cells , 1988, British journal of haematology.

[54]  C. D. Fitch,et al.  The state of ferriprotoporphyrin IX in malaria pigment. , 1987, The Journal of biological chemistry.

[55]  P. Schlesinger,et al.  Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. , 1987, The New England journal of medicine.

[56]  R. Wilson,et al.  Plasmodium falciparum: protease inhibitors and inhibition of erythrocyte invasion. , 1986, Experimental parasitology.

[57]  H. Ginsburg,et al.  Uptake of [3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum. , 1986, Biochemical pharmacology.

[58]  T. Peto,et al.  A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum‘in vitro’: the unimportance of serum iron , 1986, British journal of haematology.

[59]  I. Gluzman,et al.  Antimalarials increase vesicle pH in Plasmodium falciparum , 1985, The Journal of cell biology.

[60]  H. Ginsburg,et al.  Identification of the acidic compartment of Plasmodium falciparum‐infected human erythrocytes as the target of the antimalarial drug chloroquine. , 1984, The EMBO journal.

[61]  J. Jensen,et al.  Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. , 1983, The Journal of protozoology.

[62]  M. Pfaller,et al.  Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex , 1982, Antimicrobial Agents and Chemotherapy.

[63]  C. D. Fitch,et al.  Hemin lyses malaria parasites. , 1981, Science.

[64]  I. Sherman,et al.  Biochemistry of Plasmodium (malarial parasites). , 1979, Microbiological reviews.

[65]  C. Wilson,et al.  Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum. , 1996, Molecular and biochemical parasitology.

[66]  G. Reddy.  Determining the sequence of parasite DNA , 1995 .

[67]  G. Brittenham,et al.  Iron chelation therapy for malaria. , 1994, Advances in experimental medicine and biology.

[68]  S. Meshnick,et al.  The interaction of artemisinin with malarial hemozoin. , 1994, Molecular and biochemical parasitology.

[69]  S. Lytton,et al.  The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. , 1993, The Journal of clinical investigation.

[70]  P. Rosenthal,et al.  The proteases and pathogenicity of parasitic protozoa. , 1993, Annual review of microbiology.

[71]  S. Meshnick,et al.  Intracellular parasites. New developments in chemotherapy. , 1992, Sub-cellular biochemistry.

[72]  C. Slomianny.  Three-dimensional reconstruction of the feeding process of the malaria parasite. , 1990, Blood cells.

[73]  M. Alpers,et al.  The effect of iron therapy on malarial infection in Papua New Guinean schoolchildren. , 1989, The American journal of tropical medicine and hygiene.

[74]  W. Wernsdorfer,et al.  Plasmodial metabolism and related organellar function during various stages of the life-cycle: proteins, lipids, nucleic acids and vitamins. , 1988 .

[75]  S. Macfarlane,et al.  Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea. , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[76]  L. Scheibel.  In vitro inhibition of the human malaria parasite by selected lipophilic chelators. , 1984, Progress in clinical and biological research.